[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$cmps
Oppenheimer upgrades Compass Pathways to Outperform with a $XX target, citing conviction that COMP360 psilocybin therapy could be the first FDA-approved psychedelic treatment for depression. Recent social posts highlight significant call option buying and positive sentiment around the company's development.
About $cmps
Compass Pathways is a biotechnology company focused on developing psilocybin-based therapies for mental health.
Insights
- $cmps engagements is up XXXXXX% from the previous week.
Engagements: XXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
X Week: XXXXXX +113%
X Month: XXXXXXX +20%
X Months: XXXXXXXXX +17%
X Year: XXXXXXXXX +76%
1-Year High: XXXXXXX on 2025-06-23
1-Year Low: XXX on 2025-10-26
Engagements by network (24h): X: XXXXX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX -XX%
X Month: XXX -XX%
X Months: XXXXX +201%
X Year: XXXXX +301%
1-Year High: XXX on 2025-06-24
1-Year Low: X on 2025-12-07
Mentions by network (24h): X: XXX
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $cmps in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX
X Week: XX no change
X Month: XXX -XX%
X Months: XXXXX +422%
X Year: XXXXX +188%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-12-07
The most influential creators that mention $cmps in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @PsychedVantage | X | XXXXX | X | XXX |
| @seedy19tron | X | XXXXX | X | XXX |
| @Yam_Trades | X | XXXXX | X | XXX |
| @salmaogs | X | XXXXXX | X | XXX |
| @flobrand | X | XXXXX | X | XXX |
| @PsychedStocks | X | XXX | X | XX |
| @BOSSTRADING0 | X | XXX | X | XX |
| @seedytx19 | X | XXXXX | X | XX |
Sentiment: XXX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
X Week: XXX% no change
X Month: XXX% +14%
X Months: XXX% +20%
X Year: XXX% +4%
1-Year High: XXX% on 2024-12-23
1-Year Low: XX% on 2025-03-31
Most Supportive Themes:
- CYBN CYB003 Phase X Data: (30%) Cybin's CYB003 Phase X trial data shows promising efficacy for depression treatment, boosting investor confidence and highlighting the potential of psychedelic medicines.
- Psychedelic Sector Growth: (25%) The psychedelic sector is experiencing increased investor interest and institutional attention, driven by positive trial data and the potential for revolutionary mental health treatments.
- Compass Pathways R&D Collaboration: (15%) Compass Pathways is entering into R&D collaborations to pioneer precision treatments for various conditions, indicating advancements in their therapeutic development.
Most Critical Themes:
Top $cmps Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"pre market gainer of 12/10 $ABVX $GEV $STOK $MRVI $SATS $GPCR $PLAB $CMPS $GLUE $NMR $DRTS $HSBC $TERN $TEVA $WAT $LBRT $FMST $RZLT $PUMP"
X Link @StockxSignal 2025-12-10T14:00Z 2794 followers, XXX engagements
"Upgrades 12/10: $ABBV $ANDE $CMC $CMPS $DCBO $DYN $FNV $GEV $HP $HSBC $JBTM $LBRT $MIDD $OWL $PEP $PNR $PSN $PUMP $SATS $TEX $VALE $WAT $WPM . Downgrades 12/10: $AEM $BIIB $EMR $FER $LAKE $NE $PTEN $RACE $RCI $RIG $RRX $VLTO $VTMX"
X Link @OpenOutcrier 2025-12-10T13:55Z 79.9K followers, 1757 engagements
"$CMPS +3% Oppenheimer upgrades Compass Pathways to Outperform with a $XX target citing rising conviction that COMP360 psilocybin therapy could become the first FDA-approved psychedelic treatment for depression"
X Link @notreload_ai 2025-12-10T11:30Z 3060 followers, XXX engagements
"12/09 Flow Highlights For anyone who tracked 12/5 $BRZE playing out on earnings ( $CMP was a dud) & $PLAY calls look ok so far. Flow Multiples $SGML 10.39x Bullish Premium $PLAY 9.67x Bullish Premium $GFS 6.38x Bullish Premium $ESTA 5.2x Bullish Premium $CRMD 3.9x BUllish Premium RR/IRR $MLYS January Sell 1500x30P / Buy 1500x45C (Biotech) $CRMD March Sell 437x10P / Buy 437x13C (Anti-Bacterial Dialysis treatment) $GH January Sell 654x80P / Buy 654x125C $CORZ Feb Sell 500x15P / Buy 500x20C $TAC August Sell 831x35C / Sell 831x13P / Buy 831x10P / Buy 831x20C (1000 in total) $JNJ 12/26 Sell"
X Link @Yam_Trades 2025-12-09T21:49Z 5200 followers, 2683 engagements